Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04998786
Title A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse." (I2D IFM2021_03)
Acronym I2D IFM2021_03
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nantes University Hospital
Indications
Therapies
Age Groups: senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHR Annecy France Details
CH de la cote basque Bayonne France Details
CHRU Hopital Haut Lévêque Bordeaux France Details
CHU de Brest Brest France Details
CHU Caen France Details
CHU Clermont-Ferrand France Details
CHRU Dijon France Details
CHD les Oudairies La Roche-sur-Yon France Details
CHRU Lille Lille France Details
CHU Limoges France Details
CH Lyon Sud Lyon France Details
CHRU Nancy France Details
CHU Nantes France Details
Hopital de l'archet Nice France Details
CHU Henri Mondor Paris France Details
Hopital St Antoine Paris France Details
Hôpital Cochin Paris France Details
University Hospital Poitiers France Details
CHRU Rennes France Details
ICANS Strasbourg France Details
CHU Toulouse France Details
CHRU Bretonneau Tours France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field